Discover
GLPG
Lakefront Biotherapeutics NV
27.73
1 x 20.48
1 x 35.21
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
27.73 +0.00 (0.00%)
| Ytd | -15.20% | |
| 1y | -3.95% |
27.16
day range
28.53
26.62
52 week range
37.78
| Open | 28.53 | Prev Close | 27.73 | Low | 27.16 | High | 28.53 | Mkt Cap | 1.86B |
| Vol | 286.75K | Avg Vol | 154.82K | EPS | 8.71 | P/E | 3.18 | Forward P/E | -26.56 |
| Beta | 0.12 | Short Ratio | 6.95 | Inst. Own | 22.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 29.67 | 200-d Avg | 32.00 | 1yr Est | 27.23 |
| Income Statement | |||
| Total Revenue | 8.06M | ||
| Revenues (USD) | 9.26M | ||
| Cost of Revenue | 4.80M | ||
| Gross Profit | 3.26M | ||
| Operating Expenses | 65.39M | ||
| Research and Development Expense | 30.96M | ||
| Selling, General and Administrative Expense | 35.51M | ||
| Operating Income | -62.13M | ||
| Income Tax Expense | 70.00K | ||
| Net Income | 14.49M | ||
| Net Income Common Stock | 14.49M | ||
| Net Income Common Stock (USD) | 16.66M | ||
| Consolidated Income | 14.49M | ||
| Net Income from Discontinued Operations | -606.00K | ||
| Earnings per Basic Share | 0.22 | ||
| Earnings per Basic Share (USD) | 0.25 | ||
| Earnings per Diluted Share | 0.22 | ||
| Earning Before Interest & Taxes (EBIT) | 14.56M | ||
| Earning Before Interest & Taxes (USD) | 16.74M | ||
| Weighted Average Shares | 65.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 66.81M | ||
| Cash and Equivalents (USD) | 76.79M | ||
| Investments | 2.98B | ||
| Investments Current | 2.92B | ||
| Investments Non-Current | 69.51M | ||
| Trade and Non-Trade Receivables | 168.61M | ||
| Current Assets | 3.06B | ||
| Property, Plant & Equipment Net | 76.95M | ||
| Total Assets | 3.37B | ||
| Debt Current | 1.58M | ||
| Total Debt | 6.44M | ||
| Current Liabilities | 100.42M | ||
| Debt Non-Current | 4.85M | ||
| Total Liabilities | 119.06M | ||
| Accumulated Retained Earnings (Deficit) | 228.33M | ||
| Accumulated Other Comprehensive Income | 2.74M | ||
| Shareholders Equity | 3.25B | ||
| Shareholders Equity (USD) | 3.74B | ||
| Assets Non-Current | 311.69M | ||
| Total Debt (USD) | 7.40M | ||
| Deferred Revenue | 32.00K | ||
| Goodwill and Intangible Assets | 746.00K | ||
| Inventory | 17.69M | ||
| Liabilities Non-Current | 18.64M | ||
| Trade and Non-Trade Payables | 95.77M | ||
| Tax Assets | 163.00K | ||
| Tax Liabilities | 912.00K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -510.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -21.76M | ||
| Capital Expenditure | 1.19M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 2.34M | ||
| Issuance (Repayment) of Debt Securities | -510.00K | ||
| Net Cash Flow from Investing | 61.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 57.96M | ||
| Net Cash Flow from Operations | -94.61M | ||
| Effect of Exchange Rate Changes on Cash | 700.00K | ||